Osteoarthritis year in review 2016: clinical

N E Lane; K Shidara; B L Wise

doi:10.1016/j.joca.2016.09.025

Osteoarthritis year in review 2016: clinical

Osteoarthritis Cartilage. 2017 Feb;25(2):209-215. doi: 10.1016/j.joca.2016.09.025. Epub 2017 Jan 16.

Authors

N E Lane¹, K Shidara², B L Wise³

Affiliations

¹ Center for Musculoskeletal Health, University of California at Davis School of Medicine, Sacramento, CA 95817, USA; Department of Internal Medicine, University of California at Davis School of Medicine, Sacramento, CA 95817, USA; Affiliated Faculty, Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA 94143, USA. Electronic address: nelane@ucdavis.edu.
² Center for Musculoskeletal Health, University of California at Davis School of Medicine, Sacramento, CA 95817, USA; Department of Internal Medicine, University of California at Davis School of Medicine, Sacramento, CA 95817, USA.
³ Center for Musculoskeletal Health, University of California at Davis School of Medicine, Sacramento, CA 95817, USA; Department of Internal Medicine, University of California at Davis School of Medicine, Sacramento, CA 95817, USA; Department of Orthopaedic Surgery, University of California at Davis School of Medicine, Sacramento, CA 95817, USA.

PMID: 28100423
DOI: 10.1016/j.joca.2016.09.025

Abstract

Both epidemiologic and clinical research continues to be performed in osteoarthritis (OA). While epidemiologic studies identify risk factors for incident and progressive disease, clinical studies explore the role of both non-pharmacologic and pharmacologic treatments, including oral and intra-articular therapies. We performed a systematic review of the literature using PubMed for the time period between April 1, 2015 to February 22, 2016. Selected publications in the areas of both epidemiology and treatment are reviewed in this article.

Keywords: Epidemiology; Function; Osteoarthritis; Pain; Treatment.

Publication types

Review
Systematic Review

MeSH terms

Anti-Inflammatory Agents / administration & dosage
Anti-Inflammatory Agents / therapeutic use
Humans
Injections, Intra-Articular
Osteoarthritis / drug therapy
Osteoarthritis / epidemiology
Osteoarthritis / therapy*
Pain Management
Regenerative Medicine
Risk Factors

Substances

Anti-Inflammatory Agents

Abstract

Publication types

MeSH terms

Substances

Grants and funding